Clinical Trial Update: Tailored Treatment of Permanent Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on tailored treatment for permanent atrial fibrillation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Medtronic Cardiac Rhythm and Heart Failure

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED | Results posted: 2012-05-09